Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of drugs to try and prevent the development or
recurrence of cancer. It is not known whether eflornithine is effective in preventing cancer
in patients with Barrett's esophagus.
PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of eflornithine
in preventing cancer in patients with Barrett's esophagus.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center